Close

Alere (ALR) Receives Shareholder Support for Proposed Abbott (ABT) Merger

Go back to Alere (ALR) Receives Shareholder Support for Proposed Abbott (ABT) Merger

Alere Shareholders Approve Merger with Abbott

October 21, 2016 9:48 AM EDT

WALTHAM, Mass., Oct. 21, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced that its shareholders have voted to approve the previously announced merger with Abbott. In a final count of the voting results, over 98% of votes cast at a special meeting voted in favor of the merger, representing 77% of all outstanding Alere shares as of the August 26, 2016 record date. The final vote results will be filed on a Form 8-K with the Securities and Exchange Commission.

"The overwhelming support we received... More

People's Republic of China Clears Abbott Acquisition of Alere

October 20, 2016 11:17 AM EDT

WALTHAM, Mass., Oct. 20, 2016 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics announced that it has received notification from the Ministry of Commerce of the People's Republic of China (PRC) that after completing its review of the proposed acquisition the PRC has decided not to prohibit the acquisition of Alere Inc. by Abbott Laboratories (NYSE: ABT).

Namal Nawana, CEO and President of Alere, said, "We are very pleased by this decision and remain confident that the merger will proceed according to the... More